Position
Renaissance Technologies in Emergent BioSolutions Inc.
Back to the book · All holders of EBS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $52.5K$8.30 → $8.38
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 577.1K | $7.13M | — | — | — | 0.0% |
| Q1 2026 | 656K | $5.45M | $8.30 | −$2.34M | $654.9K | 0.0% |
| Q2 2026 | 683.2K | $5.73M | $8.38 | $52.5K | $227.9K | 0.0% |